Role of 68Ga-DOTATOC PET/CT in the Evaluation of Primary Pulmonary Carcinoids
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Although carcinoid tumors usually have good prognosis, early and specific diagnosis is important. Computed tomography and magnetic resonance imaging do not provide findings that are specific for carcinoids, and somatostatin receptor scintigraphy suffers from low spatial resolution. 18-Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) has limited sensitivity for carcinoids due to low uptake of the marker. A PET/CT system that uses the somatostatin receptor-based PET tracer 1,4,7,10-tetraazacyclododecane-NI,NII,NIII,NIIII-tetraacetic acid (D)-Phe1-thy3-octreotide (68Ga-DOTATOC) has also been used in the evaluation of carcinoids, although information regarding its use for the detection of primary pulmonary carcinoids is limited. Thus, we investigated the value of 68Ga-DOTATOC PET/CT for the diagnosis of primary pulmonary carcinoid tumors. Methods: This was a retrospective analysis of patients with primary pulmonary tumors who underwent 68Ga-DOTATOC PET/CT. All the patients had a histopathologic diagnosis of carcinoid. The rate of detection of primary pulmonary carcinoid tumors using 68Ga-DOTATOC PET/CT was assessed. Results: Twenty patients were diagnosed as having carcinoid, and 19 tumors showed significant uptake on 68Ga-DOTATOC (detection rate, 95%). The maximal standardized uptake value (SUVmax) ranged from 1.1 to 66, with a median value of 21.6. In one patient, 68Ga-DOTATOC PET/CT revealed additional lesions. Conclusions: Our results demonstrate that 68Ga-DOTATOC PET/CT is useful in the evaluation of primary pulmonary carcinoids and should be included in the diagnostic work-up of these patients. (Korean J Intern Med 2010;25:386-391)
Abstract
Background/Aims: Although carcinoid tumors usually have good prognosis, early and specific diagnosis is important. Computed tomography and magnetic resonance imaging do not provide findings that are specific for carcinoids, and somatostatin receptor scintigraphy suffers from low spatial resolution. 18-Fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) has limited sensitivity for carcinoids due to low uptake of the marker. A PET/CT system that uses the somatostatin receptor-based PET tracer 1,4,7,10-tetraazacyclododecane-NI,NII,NIII,NIIII-tetraacetic acid (D)-Phe1-thy3-octreotide (68Ga-DOTATOC) has also been used in the evaluation of carcinoids, although information regarding its use for the detection of primary pulmonary carcinoids is limited. Thus, we investigated the value of 68Ga-DOTATOC PET/CT for the diagnosis of primary pulmonary carcinoid tumors. Methods: This was a retrospective analysis of patients with primary pulmonary tumors who underwent 68Ga-DOTATOC PET/CT. All the patients had a histopathologic diagnosis of carcinoid. The rate of detection of primary pulmonary carcinoid tumors using 68Ga-DOTATOC PET/CT was assessed. Results: Twenty patients were diagnosed as having carcinoid, and 19 tumors showed significant uptake on 68Ga-DOTATOC (detection rate, 95%). The maximal standardized uptake value (SUVmax) ranged from 1.1 to 66, with a median value of 21.6. In one patient, 68Ga-DOTATOC PET/CT revealed additional lesions. Conclusions: Our results demonstrate that 68Ga-DOTATOC PET/CT is useful in the evaluation of primary pulmonary carcinoids and should be included in the diagnostic work-up of these patients. (Korean J Intern Med 2010;25:386-391)
참고문헌 (13)
- Lubarsch O, "Ueber den primaren krebs des ileum, nebst bemerkungen uber das gleichzeitige vorkommen von krebs und tuberkolose", Virchows Arch, 111, pp.280~317 (1888)
- Fink G, "Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature", Chest, 119, pp.1647~1651 (2001)
- Bajetta E, "Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors", Cancer, 86, pp.858~865 (1999)
- Ko JM, "Benign tumors of the tracheobronchial tree: CT-pathologic correlation", AJR Am J Roentgenol, 186, pp.1304~1313 (2006)
- Buchmann I, "Comparison of 68Ga- DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours", Eur J Nucl Med Mol Imaging, 34, pp.1617~1626 (2007)
- Rege SD, "Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose", Cancer, 72, pp.82~90 (1993)
- Erasmus JJ, "Evaluation of primary pulmonary carcinoid tumors using FDG PET", AJR Am J Roentgenol, 170, pp.1369~1373 (1998)
- Kruger S, "Use of integrated FDG PET", CT imaging in pulmonary carcinoid tumours, 2006, pp.260, 545~550
- Hofmann M, "Biokinetics and imaging with the somatostatin receptor PET radioligand (68)Ga-DOTATOC: preliminary data", Eur J Nucl Med, 28, pp.1751~1757 (2001)
- FDG in patients with metastatic neuroendocrine tumours scheduled for 90YDOTATOC therapy, "Eur J Nucl Med Mol Imaging", 2006, 1115~1122
- Gabriel M, "68Ga-DOTA-Tyr3- octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT", J Nucl Med, 48, pp.508~518 (2007)
- Ambrosini V, "68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid", Nucl Med Commun, 30, pp.281~286 (2009)
- Kayani I, "A comparison of 68Ga- DOTATATE and 18F-FDG PET", CT in pulmonary neuroendocrine tumors, 2009, pp.50, 1927~1932